Is the Use of Selective COX Inhibitors Associated with an Increased Risk of Cardiovascular Events?

Publisher： Karger

E-ISSN： 1424-0556|4|2|92-95

ISSN： 1422-9528

Source： Heart Drug, Vol.4, Iss.2, 2004-05, pp. : 92-95

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Temporal Relationship between Use of NSAIDs, Including Selective COX-2 Inhibitors, and Cardiovascular Risk

By Motsko Stephen P.  

Drug Safety, Vol. 29, Iss. 7, 2006-01 ,pp. : 621-632

Adis International

Access to resources Recommend Favorite

COX-2 inhibitors: increased risk of CV events?

By  

Inpharma, Vol. 1, Iss. 1303, 2001-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Potential Mechanisms of COX-2 Selective Inhibitors Affecting Cardiovascular Risk

By Smith Howard S.  

Journal of Cancer Pain & Symptom Palliation, Vol. 2, Iss. 3, 2008-01 ,pp. : 5-18

Haworth Press

Access to resources Recommend Favorite

Thiazolidinedione treatment is not associated with an increased risk of major adverse cardiovascular events

By  

Inpharma, Vol. 1, Iss. 1643, 2008-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Cardiovascular hazard of selective COX-2 inhibitors: myth or reality?

By Chiolero Arnaud   Burnier Michel   Maillard Marc P  

Expert Opinion on Drug Safety, Vol. 1, Iss. 1, 2002-05 ,pp. : 45-52

Informa Healthcare

Access to resources Recommend Favorite